11-Sept-2026 08:52:18
GLENMARKExpansion
GLENMARK PHARMA : BRAZIL LAUNCH OF RYALTRIS NASAL SPRAY
• Glenmark Specialty S.A., a wholly-owned subsidiary of Glenmark Pharmaceuticals, announced the launch of RYALTRIS® Nasal Spray in Brazil. • The product is for the treatment of moderate to severe symptoms associated with allergic rhinitis in adults and adolescents aged 12 years and older. • The launch follows regulatory approval granted by the Brazilian Health Regulatory Agency, Agência Nacional de Vigilância Sanitária (ANVISA). • RYALTRIS® is Glenmark's first globally commercialized branded innovative product, approved in 57 markets worldwide.
Glenmark Pharmaceuticals Limited
Open attachment